Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:15 PM
Ignite Modification Date:
2026-03-26 @ 3:15 PM
NCT ID:
NCT07454850
Eligibility Criteria:
Inclusion criteria
* Diagnosed with Ph+ve CML based on the European LeukemiaNet (ELN) and National Comprehensive Cancer Network (NCCN) diagnostic criteria.
* Received at least one line of TKI therapy.
* Having a documented pre-index period (equal to either 6 months prior to the index date or less in case of newly diagnosed patients).
Exclusion criteria
• Patients not fulfilling any of the above-mentioned inclusion criteria.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
21 Years
Maximum Age:
90 Years
Study:
NCT07454850
Study Brief:
Protocol Section:
NCT07454850